PARAGON takes majority stake in PRIMED

Paragon Partners invested in Primed Group, the Halberstadt-based provider of medical consumables and sterilisation services, in a deal announced on 7 November 2023 and completed at the end of October. The investment was made through The Paragon Fund III, alongside the existing management team, which stayed in place to continue the group's growth strategy. At the time of the deal, Primed employed about 470 people and manufactured at several production sites in Germany and abroad, covering every step from development and manufacturing to sterilisation and distribution. Its certified products, used in tracheostomy and laryngectomy, wound drainage, thoracic surgery and stool management, were sold to hospitals, home care providers and other medical facilities in more than 60 countries. Paragon planned to back more intensive product development and geographic expansion, investing in new products and markets and considering acquisitions to widen the range. Senior partner Dr Edin Hadzic said Primed was recognised for its work in the medical industry and that the firm saw significant growth potential. Clifford Chance advised Paragon on the investment. Paragon sold Primed Group to Inflexion in July 2026, after less than three years of ownership.